Initial regional evaluation of the Cystic Fibrosis Newborn Screening program: data from the Mediterranean coast of Turkey

Creative Commons License

BAŞARAN A. E., BAŞARAN A., KOCACIK UYGUN D. F., Alper O., Acican D., BİNGÖL A.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.49, sa.6, ss.1655-1661, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 6
  • Basım Tarihi: 2019
  • Doi Numarası: 10.3906/sag-1904-198
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1655-1661
  • Anahtar Kelimeler: Immunoreactive trypsinogen, cystic fibrosis newborn screening, IRT cut-off, Turkey, BLOOD SPOT, IDENTIFICATION, DIAGNOSIS, CHILDREN, GENE
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background/ aim: Since January 2015, the Cystic Fibrosis Newborn Screening (CFNS) program has been implemented in Turkey. We aimed to evaluate the demographic, clinical, and laboratory data of cases referred from the CFNS program and to determine the most suitable cut-off value for immunoreactive trypsinogen (IRT)-1 and immunoreactive trypsinogen (IRT-2) that are used in the CFNS program in Turkey.